VLON - Vallon Pharmaceuticals names new CFO

May, 11 2021 09:27 AM Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals (VLON) appoints Leanne Kelly as the company's new chief financial officer. Prior to joining Vallon, Kelly most recently served as the Controller and Executive Director, Global Financial Reporting at OptiNose. Overall, Kelly brings in more than 20 years of experience leading private and publicly traded companies across life science, technology and e-Commerce sectors."Following our IPO earlier this year, we have taken thoughtful steps to strengthen our team and ensure we have key people with the right expertise needed to best position the Company for success. Leanne is a great addition to the Vallon executive management team as CFO," says President and CEO David Baker.Stock down 2% in pre-market trading.Since the company's listing in February this year, VLON stock has fallen about 46% currently trading at $4.

For further details see:

Vallon Pharmaceuticals names new CFO

Company Name:	Vallon Pharmaceuticals Inc.
Stock Symbol:	VLON
Market:	NASDAQ

Twitter